ASX - By Stock
|
BOT |
Re:
Ann: Appendix 3B and Notice Under Section 708A
|
|
SteveMartin
|
20 |
20K |
1 |
25/03/19 |
25/03/19 |
ASX - By Stock
|
20
|
20K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Botanix Takeover
|
|
SteveMartin
|
65 |
27K |
3 |
25/03/19 |
25/03/19 |
ASX - By Stock
|
65
|
27K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Botanix Takeover
|
|
SteveMartin
|
65 |
27K |
2 |
25/03/19 |
25/03/19 |
ASX - By Stock
|
65
|
27K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Botanix Takeover
|
|
SteveMartin
|
65 |
27K |
6 |
24/03/19 |
24/03/19 |
ASX - By Stock
|
65
|
27K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Botanix Takeover
|
|
SteveMartin
|
65 |
27K |
3 |
23/03/19 |
23/03/19 |
ASX - By Stock
|
65
|
27K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
5 |
22/03/19 |
22/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
2 |
22/03/19 |
22/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
3 |
22/03/19 |
22/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Details of Company Address
|
|
SteveMartin
|
5 |
3.5K |
0 |
14/03/19 |
14/03/19 |
ASX - By Stock
|
5
|
3.5K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
3 |
12/03/19 |
12/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
3 |
12/03/19 |
12/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
8 |
10/03/19 |
10/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
13 |
08/03/19 |
08/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Updated Investor Presentation
|
|
SteveMartin
|
78 |
29K |
3 |
04/03/19 |
04/03/19 |
ASX - By Stock
|
78
|
29K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Updated Investor Presentation
|
|
SteveMartin
|
78 |
29K |
3 |
04/03/19 |
04/03/19 |
ASX - By Stock
|
78
|
29K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Opinion Leaders Present Botanix Data at AAD 2019
|
|
SteveMartin
|
20 |
7.4K |
4 |
04/03/19 |
04/03/19 |
ASX - By Stock
|
20
|
7.4K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Opinion Leaders Present Botanix Data at AAD 2019
|
|
SteveMartin
|
20 |
7.4K |
9 |
04/03/19 |
04/03/19 |
ASX - By Stock
|
20
|
7.4K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
5 |
03/03/19 |
03/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
3 |
03/03/19 |
03/03/19 |
ASX - By Stock
|
13K
|
4.7M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Investor Presentation
|
|
SteveMartin
|
58 |
21K |
2 |
28/02/19 |
28/02/19 |
ASX - By Stock
|
58
|
21K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Permetrex Outperforms Other CBD Topical Products
|
|
SteveMartin
|
64 |
24K |
4 |
26/02/19 |
26/02/19 |
ASX - By Stock
|
64
|
24K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Permetrex Outperforms Other CBD Topical Products
|
|
SteveMartin
|
64 |
24K |
2 |
26/02/19 |
26/02/19 |
ASX - By Stock
|
64
|
24K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
0 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
13K
|
4.7M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
SteveMartin
|
13K |
4.7M |
0 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
13K
|
4.7M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT
|
|
SteveMartin
|
159 |
67K |
5 |
27/01/19 |
27/01/19 |
ASX - By Stock
|
159
|
67K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
|
|
SteveMartin
|
197 |
82K |
3 |
11/01/19 |
11/01/19 |
ASX - By Stock
|
197
|
82K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Investor Presentation
|
|
SteveMartin
|
150 |
55K |
5 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
150
|
55K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
|
|
SteveMartin
|
197 |
82K |
1 |
04/01/19 |
04/01/19 |
ASX - By Stock
|
197
|
82K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
|
|
SteveMartin
|
197 |
82K |
1 |
03/01/19 |
03/01/19 |
ASX - By Stock
|
197
|
82K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
|
|
SteveMartin
|
197 |
82K |
5 |
03/01/19 |
03/01/19 |
ASX - By Stock
|
197
|
82K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
|
|
SteveMartin
|
197 |
82K |
3 |
03/01/19 |
03/01/19 |
ASX - By Stock
|
197
|
82K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
|
|
SteveMartin
|
197 |
82K |
4 |
03/01/19 |
03/01/19 |
ASX - By Stock
|
197
|
82K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Investor Presentation
|
|
SteveMartin
|
150 |
55K |
2 |
14/12/18 |
14/12/18 |
ASX - By Stock
|
150
|
55K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT
|
|
SteveMartin
|
159 |
67K |
3 |
03/12/18 |
03/12/18 |
ASX - By Stock
|
159
|
67K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix BTX 1503 Clinical Trial Update
|
|
SteveMartin
|
31 |
11K |
2 |
12/09/18 |
12/09/18 |
ASX - By Stock
|
31
|
11K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Expands Clinical Capabilities
|
|
SteveMartin
|
13 |
6.1K |
12 |
27/07/18 |
27/07/18 |
ASX - By Stock
|
13
|
6.1K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
BTX 1503 Phase 2 trial specifics
|
|
SteveMartin
|
96 |
44K |
3 |
12/07/18 |
12/07/18 |
ASX - By Stock
|
96
|
44K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BOT Welcomes First FDA Approval for Cannabidiol Product
|
|
SteveMartin
|
159 |
77K |
3 |
26/06/18 |
26/06/18 |
ASX - By Stock
|
159
|
77K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
The Board are 110% Right
|
|
SteveMartin
|
64 |
25K |
12 |
21/06/18 |
21/06/18 |
ASX - By Stock
|
64
|
25K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Raises A$8m in Oversubscribed Placement
|
|
SteveMartin
|
99 |
34K |
4 |
21/06/18 |
21/06/18 |
ASX - By Stock
|
99
|
34K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Buying Time
|
|
SteveMartin
|
31 |
12K |
0 |
18/06/18 |
18/06/18 |
ASX - By Stock
|
31
|
12K
|
0
|
|